• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.55% Nasdaq Up0.12%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    128.33 Down 1.43(1.10%) 12:25PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:143.40
    Median Target:144.50
    High Target:180.00
    Low Target:110.00
    No. of Brokers:10

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Mar 4, 2015BarclaysInitiated Overweight
    Feb 11, 2013MLV & CoDowngradeBuyHold
    Oct 14, 2011Rodman & RenshawInitiated Mkt Outperform
    May 6, 2011MLV CapitalInitiated Buy
    May 20, 2010ThinkEquityInitiated Buy
    Nov 24, 2009Roth CapitalDowngradeBuyHold
    Jun 10, 2009Jefferies & CoInitiated Buy
    Jun 10, 2009Roth CapitalInitiated Buy
    Feb 25, 2009NeedhamUpgradeUnderperformHold
    Aug 20, 2008Leerink SwannInitiated Underperform

    More Upgrades & Downgrades for ALNY

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2333

    Data provided by Thomson/First Call

    Currency in USD.